Paul A. Gurbel, MD

Paul Gurbel

General Statement of Disclosure:

CONSULTING FEES/HONORARIA: Bayer (SIGNIFICANT), Wolters Kluwer(MODEST), US WorldMeds(SIGNIFICANT), Vectra(SIGNIFICANT), Janssen Pharmaceuticals, Inc(MODEST), Cleveland Clinic(MODEST), Web MD Medscape(SIGNIFICANT), Baim Institute(NONE), Medforce(MODEST) RESEARCH/RESEARCH GRANTS: Haemonetics(SIGNIFICANT), Janssen Pharmaceuticals, Inc(SIGNIFICANT), Bayer(SIGNIFICANT), Instrumentation Labs(SIGNIFICANT), Hikari Dx(SIGNIFICANT), Us WorldMeds(SIGNIFICANT), Vectra(SIGNIFICANT), Novartis Corporation(SIGNIFICANT), LabCorp Drug Development(SIGNIFICANT), Idorsia(SIGNIFICANT), Prolocor(MODEST), AstraZeneca Pharmaceuticals(SIGNIFICANT), Recor(SIGNIFICANT), Janssen Pharmaceuticals, Inc(SIGNIFICANT) OTHER FINANCIAL BENEFIT: Baron and Bud(SIGNIFICANT)

View Full Disclosure